Our data also supported this effect of metformin with the finding of reduced TNF-α levels in Metformin-treated rats compared to PCOS group and in addition suggests that this effect may be mediated through AMPK activation since AMPK immunreactivity was higher in the metformin and combined treatment groups compared to the PCOS group. This evidence concerns the gene TNF and polycystic ovary syndrome.